rs10501316

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001352027.3(PHF21A):​c.153+7755G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.138 in 152,104 control chromosomes in the GnomAD database, including 1,643 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.14 ( 1643 hom., cov: 32)

Consequence

PHF21A
NM_001352027.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.808

Publications

3 publications found
Variant links:
Genes affected
PHF21A (HGNC:24156): (PHD finger protein 21A) The PHF21A gene encodes BHC80, a component of a BRAF35 (MIM 605535)/histone deacetylase (HDAC; see MIM 601241) complex (BHC) that mediates repression of neuron-specific genes through the cis-regulatory element known as repressor element-1 (RE1) or neural restrictive silencer (NRS) (Hakimi et al., 2002 [PubMed 12032298]).[supplied by OMIM, Nov 2010]
PHF21A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Potocki-Shaffer syndrome
    Inheritance: AD Classification: STRONG Submitted by: G2P

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001352027.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001352027.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PHF21A
NM_001352027.3
MANE Select
c.153+7755G>A
intron
N/ANP_001338956.1Q96BD5-3
PHF21A
NM_001441167.1
c.174+7755G>A
intron
N/ANP_001428096.1
PHF21A
NM_001441168.1
c.174+7755G>A
intron
N/ANP_001428097.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PHF21A
ENST00000676320.1
MANE Select
c.153+7755G>A
intron
N/AENSP00000502222.1Q96BD5-3
PHF21A
ENST00000323180.10
TSL:1
c.153+7755G>A
intron
N/AENSP00000323152.6Q96BD5-2
PHF21A
ENST00000863274.1
c.174+7755G>A
intron
N/AENSP00000533333.1

Frequencies

GnomAD3 genomes
AF:
0.138
AC:
21048
AN:
151986
Hom.:
1644
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0891
Gnomad AMI
AF:
0.167
Gnomad AMR
AF:
0.103
Gnomad ASJ
AF:
0.0992
Gnomad EAS
AF:
0.150
Gnomad SAS
AF:
0.137
Gnomad FIN
AF:
0.199
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.169
Gnomad OTH
AF:
0.120
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.138
AC:
21059
AN:
152104
Hom.:
1643
Cov.:
32
AF XY:
0.139
AC XY:
10301
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.0893
AC:
3708
AN:
41502
American (AMR)
AF:
0.102
AC:
1567
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0992
AC:
344
AN:
3468
East Asian (EAS)
AF:
0.150
AC:
776
AN:
5176
South Asian (SAS)
AF:
0.136
AC:
657
AN:
4826
European-Finnish (FIN)
AF:
0.199
AC:
2099
AN:
10566
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.169
AC:
11467
AN:
67960
Other (OTH)
AF:
0.119
AC:
252
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
907
1814
2720
3627
4534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.155
Hom.:
3535
Bravo
AF:
0.129
Asia WGS
AF:
0.136
AC:
472
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.52
DANN
Benign
0.45
PhyloP100
-0.81
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10501316;
hg19: chr11-46090550;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.